Assembly Bill A9902

Signed By Governor
2023-2024 Legislative Session

Includes nasal sprays in topical therapeutic pharmaceutical agents optometrists are authorized to use

download bill text pdf

Sponsored By

Current Bill Status Via S8768 - Signed by Governor

  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions
Votes

co-Sponsors

2023-A9902 (ACTIVE) - Details

See Senate Version of this Bill:
S8768
Law Section:
Education Law
Laws Affected:
Amd §7101-a, Ed L

2023-A9902 (ACTIVE) - Summary

Includes nasal sprays in topical therapeutic pharmaceutical agents optometrists are authorized to use.

2023-A9902 (ACTIVE) - Bill Text download pdf 

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   9902
 
                           I N  A S S E M B L Y
 
                              April 26, 2024
                                ___________
 
 Introduced by M. of A. McDONALD -- read once and referred to the Commit-
   tee on Higher Education
 
 AN ACT to amend the education law, in relation to including nasal sprays
   in  topical therapeutic pharmaceutical agents optometrists are author-
   ized to use
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section  1.  Subdivision  1  of section 7101-a of the education law is
 amended by adding a new paragraph (e-1) to read as follows:
   (E-1) NASAL  SPRAYS  AS  TOPICAL  THERAPEUTIC  PHARMACEUTICAL  AGENTS.
 TOPICAL THERAPEUTIC PHARMACEUTICAL AGENTS SHALL ALSO INCLUDE THOSE DRUGS
 LISTED  IN  SUBPARAGRAPH (III) OF PARAGRAPH (F) OF THIS SUBDIVISION THAT
 ARE ADMINISTERED THROUGH A NASAL SPRAY FOR  THE  TREATMENT  OF  DRY  EYE
 DISEASE.
   § 2. This act shall take effect immediately.
 
 
 
 
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD14764-03-4

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.